title: Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy.
abstract: OBJECTIVE
  To investigate whether there is a relationship between serum 1,25 dihydroxy vitamin D3 [1,25(OH)2D3], which is an inhibitor of angiogenesis, concentrations and severity of diabetic retinopathy (DR).
  
  
  METHODS
  Serum 1,25(OH)2D3, 25 hydroxy vitamin D [25(OH)D] and parathormone (PTH) concentrations were measured in diabetic patients (n = 66) and nondiabetic healthy subjects (n = 20).
  
  
  RESULTS
  The mean serum 1,25(OH)2D3 concentration in diabetic patients was lower than that in nondiabetics (57.3+/-21.44 vs. 89.4+/-18.01 pmol/L, p<0.001); mean 1,25(OH)2D3 concentrations fell with increasing severity of DR [being 63.4+/-17.26 pmol/L for background DR (BDR), 47.7+/-13.27 pmol/L for preproliferative DR (pre-PDR), and 43.1+/-19.45 pmol/L for proliferative DR (PDR)]. Compared with the control group, serum 25(OH)D concentrations were found to be decreased in diabetic patients (p<0.001). There were negative correlations between 1,25(OH)2D3 and age (r = -0.331, p<0.01) and duration of diabetes (r = -0.255, p<0.05).
  
  
  CONCLUSIONS
  From these findings, it was found that there was an inverse relationship between the severity of the retinopathy, i.e., neovascularization, and serum 1,25(OH)2D3 concentrations, being the lowest in PDR and the highest in diabetic patients without retinopathy (NDR) patients. The measurement of serum 1,25(OH)2D3 concentrations might be helpful to predict severity of DR in patients with diabetes mellitus.
authors.affiliation: Department of Biochemistry, Atatürk University School of Medicine, Erzurum, Turkey. yaksoy@yahoo.com
authors.forename: H
authors.initials: H
authors.lastname: Aksoy
authors.forename: F
authors.initials: F
authors.lastname: Akçay
authors.forename: N
authors.initials: N
authors.lastname: Kurtul
authors.forename: O
authors.initials: O
authors.lastname: Baykal
authors.forename: B
authors.initials: B
authors.lastname: Avci
mesh_terms: D000367:Age Factors; D020533:Angiogenesis Inhibitors / Q000097:blood*; D002112:Calcifediol / Q000097:blood*; D002118:Calcium / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications; D003930:Diabetic Retinopathy / Q000097:blood* / Q000378:metabolism; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D010758:Phosphorus / Q000097:blood; D011237:Predictive Value of Tests; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D020533:Angiogenesis Inhibitors; D002112:Calcifediol; D002118:Calcium; D006442:Glycated Hemoglobin; D010281:Parathyroid Hormone; D010758:Phosphorus; D014807:Vitamin D; C118756:dihydroxy-vitamin D3